Status:
RECRUITING
Ultrasound-Guided Percutaneous Neuromodulation on the Superior Gluteal Nerve in Patients With Greater Trochanteric Pain Syndrome: A Pilot Study
Lead Sponsor:
Universidad de Zaragoza
Conditions:
Greater Trochanteric Pain Syndrome
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
Greater Trochanteric Pain Syndrome (GTPS) predominantly affects women, with an annual incidence of 1.8 to 5.6 per 1000 individuals and a prevalence ratio of 4:1 compared to men. It is characterized by...
Detailed Description
Greater Trochanteric Pain Syndrome (GTPS) is a condition primarily affecting women, with an annual incidence ranging from 1.8 to 5.6 per 1000 individuals and a prevalence ratio of 4:1 compared to men....
Eligibility Criteria
Inclusion
- Suffering from Greater Trochanteric Pain Syndrome (GTPS).
- Experiencing local pain upon palpation of the greater trochanter area.
- Having pain in the greater trochanter region lasting more than three months, indicating chronicity.
- Being over 18 years of age.
- Experiencing pain when bearing weight on the affected trochanter.
- Having pain that impairs the functionality of resisted hip abduction.
Exclusion
- Radiological evidence of pathology in the hip or knee joints.
- Blood coagulation disorders.
- Use of oral anticoagulants.
- Presence of infections.
- History of disc or hip surgery.
- Presence of dysplasia, deformities, or sciatica.
- History of vascular, neurological, or neoplastic diseases.
- Specific contraindications for ultrasound-guided percutaneous neuromodulation (UG-PNM): belenophobia, pregnancy, pacemakers, epilepsy.
Key Trial Info
Start Date :
May 26 2025
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
September 1 2026
Estimated Enrollment :
50 Patients enrolled
Trial Details
Trial ID
NCT06529783
Start Date
May 26 2025
End Date
September 1 2026
Last Update
June 2 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University of Zaragoza
Zaragoza, Zaragoza, Spain, 50009